Nancy L. Reaven, MA

home / authors / nancy-l-reaven-ma

Articles

June 21st 2017

All-Cause Costs Increase Exponentially with Increased Chronic Kidney Disease Stage

Ladan Golestaneh, MD, MS Paula J. Alvarez, RPh, MPH, MBA Nancy L. Reaven, MA Susan E. Funk, MBA, FACHE Karen J. McGaughey, PhD Alain Romero, PhD Melanie S. Brenner, PharmD, BCPS Macaulay Onuigbo, MD, MSc, MBA

August 31st 2016

Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldosterone System Inhibitors

Murray Epstein, MD Paula J. Alvarez, RPh, MPH, MBA Nancy L. Reaven, MA Susan E. Funk, MBA, FACHE Karen J. McGaughey, PhD Melanie S. Brenner, PharmD, BCPS Wade Benton, PharmD Ladan Golestane

September 16th 2015

Evaluation of the Treatment Gap Between Clinical Guidelines and the Utilization of Renin-Angiotensin-Aldosterone System Inhibitors

Murray Epstein, MD Nancy L. Reaven, MA Susan E. Funk, MBA Karen J. McGaughey, PhD Nina Oestreicher, PhD John Knispel, MD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Glaucoma | Image credit: Alessandro Grandini - stock.adobe.com

Published: November 21st 2024 | Updated: November 24th 2024

Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions